Fuda Cancer Hospital
Leukemia chemotherapy in China typically costs from $16,500 to $38,000. The final price depends on the hospital type, drug selection, and treatment phase. In the US, similar procedures cost around $35,000 on average. Patients save around 53% compared to US prices. Standard international packages often include diagnostics, initial chemotherapy cycles, and hospital stays.
Bookimed Expert Insight: China offers high-value options for complex blood diseases at JCI-accredited facilities. Fuda Cancer Hospital in Guangzhou is world-renowned for late-stage cancer treatment. Lu Daopei Hematology Hospital in Beijing provides specialized care for refractory leukemia. Beijing Kyoto Children's Hospital focuses on high-risk pediatric cases. Choosing these specialized hubs ensures access to experienced hematologists and advanced protocols.
| China | Turkey | Austria | |
| Leukemia chemotherapy | from $16,500 | from $8,000 | from $15,000 |
Day 1
Day 2
Day 3
Day 4 - Day 10 (Treatment Days)
Day 11 - Day 14 (Post-Treatment)
Week 2 - Week 4 (Rehabilitation)
Please note that each patient"s recovery timeline may vary based on individual circumstances and the severity of the disease.
Dr. Li Ping, M.D., Ph.D., is Chief Physician and Professor in the Department of Hematology at Shanghai Tongji Hospital, Tongji University School of Medicine. She supervises doctoral and master's students and is an expert in hematologic malignancies.
She earned a Doctor of Medical Science from Nagoya University and completed postdoctoral research. She specializes in diagnosing and treating blood cancers. Her focus includes lymphoid malignancies—leukemias, lymphomas, and multiple myeloma. She treats patients with chemotherapy, hematopoietic stem cell transplantation, targeted therapy, and immunotherapy.
She is a pioneer in China in full-cycle CAR-T therapy for relapsed or refractory blood cancers. She leads and participates in national and international clinical trials. She serves on committees of professional societies, including the China Anti-Cancer Association. She also publishes and trains hematologists.
Dr. Ding Yi is the Associate Chief Physician in Hematology at Shanghai Tongji Hospital. She is also the acting deputy director of the Blood Transfusion Department. She holds a Master of Medicine from Tongji University. She serves on the Youth Committee of the Shanghai Society of Hematology.
She is skilled in diagnosing and treating leukemia, lymphoma, and myeloma. She offers hematopoietic and umbilical cord blood stem cell therapies. She specializes in acute leukemia. She developed sequential treatment protocols. She participated in research that won the Second Prize of the Shanghai Science and Technology Progress Award. She has published more than 10 papers.
Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.